News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
877,619 Results
Type
Article (83743)
Company Profile (372)
Press Release (793480)
Multimedia
Podcasts (283)
Webinars (44)
Section
Business (263984)
Career Advice (4041)
Deals (39611)
Drug Delivery (246)
Drug Development (90902)
Employer Resources (212)
FDA (18689)
Job Trends (17269)
News (393994)
Policy (39431)
Tag
2025 Best Places to Work (23)
2026 Best Places to Work (36)
2027 BioCapital Standard (4)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Standard (6)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (3112)
Academic (2)
Accelerated approval (76)
ADA (54)
Adcomms (44)
Allergies (237)
Alliances (56556)
ALS (293)
Alzheimer's disease (2150)
Antibody-drug conjugate (ADC) (776)
Approvals (19289)
Artificial intelligence (1102)
ASCO (350)
Autoimmune disease (536)
Automation (84)
Bankruptcy (406)
Belgium (45)
Best Places to Work (12626)
BIO (82)
Biologics (121)
BIOSECURE Act (23)
Biosimilars (308)
BioSpace Insights (270)
Biotechnology (258)
Bispecific (60)
Bladder cancer (251)
Brain cancer (103)
Breast cancer (978)
Cancer (8041)
Cardiovascular disease (682)
Career advice (3515)
Career pathing (65)
CAR-T (464)
CDC (82)
CDMO (236)
Celiac Disease (7)
Cell-line development (2)
Cell therapy (1260)
Cervical cancer (69)
Clinical research (80236)
Collaboration (2892)
Commercialization (76)
Company closure (10)
Compensation (1937)
Complete response letters (128)
COVID-19 (3087)
CRISPR (155)
CRO (8)
C-suite (1713)
Cystic fibrosis (183)
Data (11179)
Decentralized trials (4)
Denatured (112)
Depression (230)
Dermatology (208)
Diabetes (847)
Diagnostics (7944)
Digital health (84)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (538)
Drug pricing (254)
Drug shortages (41)
Duchenne muscular dystrophy (388)
Earnings (103639)
Editorial (85)
Employer branding (27)
Employer resources (184)
ESMO (440)
Events (139428)
Executive appointments (1384)
Eye disease (28)
FDA (23807)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (43)
Funding (2377)
Gene editing (323)
Generative AI (106)
Gene therapy (984)
GLP-1 (1415)
Government (5609)
Grass and pollen (8)
Guidances (446)
Healthcare (21502)
Hematology (236)
HIV (126)
Huntington's disease (93)
Idiopathic pulmonary fibrosis (16)
IgA nephropathy (155)
Immunology and inflammation (431)
Immuno-oncology (166)
Indications (299)
Infectious disease (3546)
Inflammatory bowel disease (285)
Inflation Reduction Act (17)
Influenza (167)
Intellectual property (390)
Interviews (802)
IPO (17967)
IRA (61)
Job creations (4917)
Job search strategy (2791)
JPM (73)
Kidney cancer (31)
Kidney disease (182)
Labor market (152)
Layoffs (732)
Leadership (70)
Legal (9925)
Licensing (132)
Liver cancer (121)
Longevity (57)
Lung cancer (1109)
Lung diease (27)
Lymphoma (567)
Machine learning (78)
Management (72)
Manufacturing (1646)
Marketing (40)
MASH (260)
Medical affairs (5)
Medical device (15460)
Medtech (15797)
Mergers & acquisitions (23201)
Metabolic disorders (2164)
Middle East (2)
mRNA (345)
Multiple sclerosis (263)
Multispecific (6)
NASH (24)
Netherlands (41)
Neurodegenerative disease (636)
Neuropsychiatric disorders (154)
Neuroscience (4366)
Neurotech (3)
NextGen: Class of 2026 (7628)
Non-profit (5176)
Now hiring (101)
Obesity (1027)
Opinion (410)
Ovarian cancer (300)
Pain (351)
Pancreatic cancer (459)
Parkinson's disease (494)
Partnered (51)
Patents (814)
Patient advocacy (8)
Patient recruitment (988)
Patient selection (117)
Peanut (81)
People (68047)
Peptides (45)
Pharmaceutical (72)
Pharmacy benefit managers (43)
Phase 1 (24803)
Phase 2 (34929)
Phase 3 (26376)
Pipeline (14699)
Policy (435)
Postmarket research (3351)
Preclinical (10979)
Press Release (74)
Prostate cancer (412)
Psychedelics (105)
Radioligand (3)
Radiopharmaceuticals (448)
Rare diseases (1617)
Real estate (7286)
Recruiting (84)
Regenerative medicine (38)
Regulatory (31583)
Reports (102)
Research institute (2816)
Resumes & cover letters (632)
Rett syndrome (60)
RNA editing (39)
RSV (107)
Saudi Arabia (1)
Schizophrenia (231)
Series A (410)
Series B (285)
Service/supplier (16)
Sickle cell disease (153)
Special edition (38)
Spinal muscular atrophy (201)
Sponsored (61)
Startups (4308)
State (2)
Stem cells (8)
Stomach cancer (24)
Substance use disorders (23)
Supply chain (173)
Switzerland (25)
Tariffs (108)
Tax incentives (2)
The Weekly (168)
Vaccines (1444)
Venture capital (186)
Weight loss (681)
Wet AMD (7)
Women's health (190)
Women in leadership (2)
Worklife (28)
Date
Today (217)
Last 7 days (947)
Last 30 days (4002)
Last 365 days (33708)
2026 (30553)
2025 (32514)
2024 (37534)
2023 (42563)
2022 (53926)
2021 (58717)
2020 (57659)
2019 (51319)
2018 (39101)
2017 (37015)
2016 (37950)
2015 (44288)
2014 (39480)
2013 (35907)
2012 (37095)
2011 (37016)
2010 (36569)
Location
Africa (1270)
Alabama (118)
Alaska (7)
Arizona (488)
Arkansas (17)
Asia (52171)
Australia (9037)
California (17344)
Canada (4746)
China (2068)
Colorado (772)
Connecticut (775)
Delaware (548)
Europe (119677)
Florida (2629)
Georgia (567)
Hawaii (5)
Idaho (70)
Illinois (1492)
India (155)
Indiana (786)
Iowa (36)
Japan (781)
Kansas (159)
Kentucky (68)
Louisiana (72)
Maine (99)
Maryland (2042)
Massachusetts (12527)
Michigan (474)
Minnesota (945)
Mississippi (8)
Missouri (190)
Montana (38)
Nebraska (31)
Nevada (206)
New Hampshire (93)
New Jersey (4583)
New Mexico (38)
New York (4519)
North Carolina (2244)
North Dakota (14)
Northern California (8879)
Ohio (539)
Oklahoma (32)
Oregon (55)
Pennsylvania (3315)
Puerto Rico (38)
Rhode Island (65)
South America (1636)
South Carolina (105)
South Dakota (2)
Southern California (6927)
Tennessee (285)
Texas (2884)
United States (61419)
Utah (528)
Vermont (2)
Virginia (436)
Washington D.C. (89)
Washington State (1383)
West Virginia (4)
Wisconsin (200)
Wyoming (6)
877,619 Results for "la jolla institute for allergy and immunology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference
October 7, 2026
·
4 min read
Press Releases
BioCryst to Present New Data for ORLADEYO® (berotralstat) and Navenibart at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting
October 29, 2026
·
7 min read
Press Releases
La Jolla Labs Inc., Unravel Biosciences Inc., and Ulm University Announce Strategic Collaboration to Advance AI-Driven Therapeutics for ALS
July 16, 2026
·
1 min read
Press Releases
Organon to Present New Analysis on VTAMA® (tapinarof) cream, 1% at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting
November 6, 2026
·
3 min read
La Jolla Institute for Immunology and RevolKa started a Research Collaboration
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology agreed to start a research collaboration to create antigens for the next-generation vaccines to deliver innovative solutions to unmet medical need in infectious diseases.
April 18, 2024
·
2 min read
Press Releases
Bruker Announces that Institute Director, Biopharma Entrepreneur and Immunology Leader Dr. Eicke Latz will join its Board of Directors
November 16, 2026
·
4 min read
Press Releases
The Gene Lay Institute of Immunology and Inflammation Expands World-Class Research Leadership, Appointing Four New Members
October 27, 2026
·
4 min read
Press Releases
La Jolla Labs, Inc. Announces First Patient Treated with Custom Antisense Therapy GBFsen for familial ALS
April 30, 2026
·
1 min read
Immunology and inflammation
6 immunology targets to sustain a mammoth I&I market
Johnson & Johnson, Pfizer, Argenx and more are unlocking new immunology targets and looking to improve on existing ones in an attempt to catch some of the magic brought about by AbbVie’s Humira and Sanofi and Regeneron’s Dupixent.
September 28, 2026
·
8 min read
·
Tristan Manalac
Press Releases
Food Allergy Science Initiative Marks 10 Years With Launch of Food Allergy Medicines Accelerator™
October 7, 2026
·
4 min read
1 of 87,762
Next